Produção de comprimidos
trials for proof of efficacy and safety, product
manufacturing for the availability of the drug on
the market. Cristália’s PD&I Center opened in 2009,
bringing together all the planning and coordination
of research carried out by the company, which
now has about 120 projects of new medicines in
progress. “Cristália is the only laboratory that
produces AFIs (Pharmaceutical Asset Ingredients)
nationally for self supply, which makes us more
competitive. We manufacture about 42 percent of
Visite:
Cristália Produtos Químicos
e Farmacêuticos Ltda.
page 407
September 2012
